ライフサイエンスコーパス: kappa

1 he reference standard (0.943 and 0.931 Cohen kappa).

2 dified Bland-Altman model and Cohen's kappa (kappa).

3 in 86%; the remainder had IgM lambda or IgG kappa.

4 at constitutively and stably expressed chIFN-kappa.

5 s, linear regression, and quadratic-weighted kappa.

6 nanocomposites (phi 10 mmxh 10 mm) with low kappa (0.48 W m(-1) K(-1) ) and the highest z T (1.18) a

7 inimal agreement on technical image quality (kappa = 0.0796; 95% confidence interval [CI]: 0.07, 0.08

8 owed a very wide range of agreement (Cohen's kappa = 0.10-0.83).

9 emia (68%; kappa = 0.36) and arthritis (66%; kappa = 0.14).

10 , 18) and only fair interobserver agreement (kappa = 0.32; 95% CI: 0.16, 0.47).

11 greement was lowest for hyperlipidemia (68%; kappa = 0.36) and arthritis (66%; kappa = 0.14).

12 appa = 0.37), NRS-itch (kappa = 0.49), POEM (kappa = 0.37), and DLQI (kappa = 0.40).

13 (kappa = 0.39), SCORAD (kappa = 0.47), EASI (kappa = 0.37), NRS-itch (kappa = 0.49), POEM (kappa = 0.

14 ously developed severity strata for oSCORAD (kappa = 0.39), SCORAD (kappa = 0.47), EASI (kappa = 0.37

15 eptiform versus non-epileptiform outcome was kappa = 0.40 (95% CI 0.25, 0.55).

16 appa = 0.49), POEM (kappa = 0.37), and DLQI (kappa = 0.40).

17 f melanocytes in hematoxylin-eosin sections (kappa = 0.422, P < .001).

18 Moderate agreement (Kappa = 0.424) was observed between hotspots defined bas

19 y strata for oSCORAD (kappa = 0.39), SCORAD (kappa = 0.47), EASI (kappa = 0.37), NRS-itch (kappa = 0.

20 appa = 0.47), EASI (kappa = 0.37), NRS-itch (kappa = 0.49), POEM (kappa = 0.37), and DLQI (kappa = 0.

21 cular localization of pagetoid cells by RCM (kappa = 0.499, P < .001).

22 wed only a moderate interobserver agreement (kappa = 0.51).

23 ility for the diagnosis of glaucoma (Pictor: kappa = 0.54, CI, 0.46-0.61; Topcon: kappa = 0.63, CI, 0

24 e PS/NS distinction increased from moderate (kappa = 0.54; 95% confidence interval [CI]: 0.37, 0.71)

25 reement ranged from moderate to substantial (kappa = 0.55-0.67).

26 r agreement was moderate for Nakanuma stage (kappa = 0.56) and substantial for Nakanuma component fib

27 shak stage (kappa = 0.64), and Ludwig stage (kappa = 0.62).

28 erver agreement upon repeat grading (Pictor: kappa = 0.63 and 0.64, for graders 1 and 2, respectively

29 Pictor: kappa = 0.54, CI, 0.46-0.61; Topcon: kappa = 0.63, CI, 0.55-0.70) and moderate intraobserver

30 ponent fibrosis (kappa = 0.67), Ishak stage (kappa = 0.64), and Ludwig stage (kappa = 0.62).

31 R imaging and among readers was substantial (kappa = 0.66; 95% confidence interval: 0.61, 0.70).

32 substantial for Nakanuma component fibrosis (kappa = 0.67), Ishak stage (kappa = 0.64), and Ludwig st

33 d diagnoses in administrative data was good (kappa = 0.68).

34 est weighted kappa coefficient of agreement (kappa = 0.69) was as follows: 0 (no itch), 1-3 (mild itc

35 terprotocol agreement was good to very good (kappa = 0.70-0.81).

36 0.86; false findings, 3), organ involvement (kappa = 0.70; 95%CI, 0.64-0.76; false findings, 5), and

37 se findings, 5), and lymph node involvement (kappa = 0.71; 95%CI, 0.65-0.78; false findings, 6).

38 , for graders 1 and 2, respectively; Topcon: kappa = 0.72 and 0.80, for graders 1 and 2, respectively

39 cificity, 86%-89% and 86%-90%, respectively; kappa = 0.74) and SMV beaking (sensitivity and specifici

40 reement between the 2 experienced observers (kappa = 0.77), the inexperienced observers showed only a

41 cificity (96%-99% and 90%-99%, respectively; kappa = 0.79).

42 at is, positive versus negative scan result (kappa = 0.80; 95%CI, 0.74-0.86; false findings, 3), orga

43 c MR imaging interpretation was substantial (kappa = 0.81).

44 cificity, 80%-88% and 94%-95%, respectively; kappa = 0.83).

45 The interobserver agreement was excellent (kappa = 0.85).

46 nostic concordance was 89% (95% CI, 75%-97%; kappa = 0.88) in a subgroup of 37 participants with phot

47 nce interval [CI]: 0.37, 0.71) to excellent (kappa = 0.89; 95% CI: 0.80, 0.98) between the first and

48 was 4 for 99% (283 of 286) of the segments (kappa = 0.9).

49 th agreement of 63% (< 90% v >/= 90%; simple kappa = -0.0301).

50 assigned to a low-risk profile by the 70-GS (kappa, 0.02; 95% CI, -0.08 to 0.11).

51 tion of small opacity profusion (subcategory kappa, 0.2352; 95% CI: 0.22, 0.25).

52 ir for peripheral distribution of follicles (kappa, 0.37).

53 arding questions about glaucoma progression (kappa, 0.39; 95% CI, 0.32-0.48) and consideration about

54 ) and consideration about treatment changes (kappa, 0.39; 95% CI, 0.32-0.48).

55 (51%-85% agreement with reference standard, kappa, 0.41-0.63), for the diagnosis of skin cancer.

56 th the VF progression software was moderate (kappa, 0.48; 95% CI, 0.41-0.55) and similar to OCT progr

57 rity and preventability (agreement, 68%-90%; kappa, 0.50-0.68).

58 55) and similar to OCT progression software (kappa, 0.52; 95% CI, 0.44-0.59).

59 (95% confidence interval [CI], 94.3 to 96.9; kappa, 0.57).

60 t was substantial among the US pathologists (kappa, 0.63; 95% CI, 0.61-0.66) and European pathologist

61 Fair to good interobserver agreement (kappa, 0.72) was observed for diagnosing carotid webs at

62 stantial for absence of a dominant follicle (kappa, 0.74), moderate for FPO-9 (ICC, 0.54) and FPO-5 (

63 5% CI, 0.61-0.66) and European pathologists (kappa, 0.80; 95% CI, 0.74-0.97).

64 5% confidence interval [CI], 98.6% to 99.2%; kappa, 0.89), with the Lumipulse G TP-N having a shorter

65 85% agreement with reference standard, Cohen kappa, 0.90) when compared with teledermatology (51%-85%

66 , the BD Max xEBP showed a high correlation (kappa, 0.97; 95% CI, 0.95 to 0.98) with the conventional

67 he presence of SNTI by standard correlation (kappa, -0.07; 95% CI, -0.29 to 0.14; P = .49) nor by uni

68 Cohen's kappa: 0.351 site investigator/CILD, 0.519 site investig

69 ut chance-corrected agreement was only fair (kappa=0.29).

70 reement between the two frameworks was fair (kappa=0.326).

71 th eccentric jets showed moderate agreement (kappa=0.53; 95% confidence interval, 0.41-0.64).

72 nd outlier agreement improved substantially (kappa=0.60).

73 In contrast, a very good agreement (kappa=0.90; 95% confidence interval, 0.82-0.98) was obse

74 and 3, glutathione S-transferase peroxidase kappa 1, and glutathione peroxidase) than the BN rat, su

75 dead) for only 0.47% of all linked records (kappa = 1.00).

76 ords iron(II)-nitroxido complexes ((Ar) L)Fe(kappa(1) -TEMPO) and ((Ar) L)Fe(kappa(2) -N,O-AZADO) ((A

77 We propose that a value of kappas=1.1 (at RH=90%) is used to represent the hygrosco

78 ted administration of an active dose of Opra Kappa (10 mg p.o. daily, four consecutive days in compar

79 orus(V) intermediate, yielding (C5 Me5 )2 Th[kappa(2) -(C,C')-(CH2 )(CH2 )PPh2 ]Cl.

80 atinum (boryl)iminomethane (BIM) complex [Pt(kappa(2) -N,B-(Cy2) BIM)(CNAr(Dipp2) )] can effect the o

81 s ((Ar) L)Fe(kappa(1) -TEMPO) and ((Ar) L)Fe(kappa(2) -N,O-AZADO) ((Ar) L=1,9-(2,4,6-Ph3 C6 H2 )2 -5-

82 These unusual transformations involving a (kappa(2) -P,N)Pt(eta(3) -benzyl) complex, and either pin

83 enerate octahedral ammine complexes that are kappa(2)-chelated by the conjugate base.

84 nd olefin-bound, cyclometalated dimers [RuCl(kappa(2)-H2IMes-H)(H2C horizontal lineCHR)]2 Ru-3.

85 f thiol RSH on the bound nitrite in [Cu(II)](kappa(2)-O2N) that leads to S-nitrosation to give the S-

86 inato copper(II) nitrito complex [Cl2NNF6]Cu(kappa(2)-O2N).THF, thiols mediate reduction of nitrite t

87 ssociation of CN(-), leading to a less rigid kappa(2)-phosphoramidite-neutral Pd intermediate.

88 Bu)4)(POCOP)Ir(CO)(H)]OTf [((tBu)4)(POCOP) = kappa(3)-C6H3-2,6-(OP((t)Bu)2)2] complexes results in ob

89 Bifunctional Mo complexes, [CpMo(CO)(kappa(3)-P2N2)](+) (P2N2 = 1,5-diaza-3,7-diphosphacycloo

90 minal zinc and magnesium hydride compounds, [kappa(3)-Tism(Pr(i)Benz)]ZnH and [Tism(Pr(i)Benz)]MgH, w

91 The highest agreement (kappa=.44) was found with a cutoff value of 3 and 5 mm f

92 h sodium salts, with the resulting catalyst [kappa(5) -((15c5) NCOP(iPr) )Ir(H)](+) exhibiting modest

93 0.96]) and similar for OCT software (overall kappa [95% CI], 0.59 [0.46-0.71] to 0.85 [0.76-0.94]).

94 l to almost perfect for VF software (overall kappa [95% CI], 0.59 [0.46-0.72] to 0.87 [0.79-0.96]) an

95 Radiologist reliability was assessed by kappa; a Hui-Walter model was used to estimate, after ac

96 ved in serum prolactin levels following Opra Kappa administration, but modest increases in circulatin

97 a potent (Ki = 0.63 nM) and highly selective kappa agonist (EC50 = 1.8 nM) selective for the peripher

98 nomolar kappa-opioid receptor affinity, full kappa agonistic activity in the [(35)S]GTPgammaS assay,

99 In order to develop novel kappa agonists restricted to the periphery, a diastereo-

100 Encapsulation causes 35-55% suppression in kappa and approximately 40% enhancement in S compared wi

101 ed of having PCOS to assess reproducibility (kappa and intraclass correlation coefficients [ICCs]).

102 Light chains kappa and lambda are immunoglobulin constituents but als

103 nificantly more CD19 B cells expressing both kappa and lambda compared with healthy controls (median

104 Kappa and lambda light chains and IgH genes are main par

105 Results were compared using Cohen's kappa and linear regression, respectively.

106 y Tic pharmacophore, are better tolerated at kappa and mu receptors and yield very high affinity mult

107 can be applied to rule-based models from the Kappa and Simmune frameworks also.

108 Frameworks such as BioNetGen, Kappa and Simmune use "reaction rules" to specify bioche

109 ith high porosity, low thermal conductivity (kappa) and excellent figure of merit (z T).

110 rferon regulator IRF1, kappa interferon (IFN-kappa), and viral restriction factors (IFIT1, -2, -3, an

111 akizumab is a high-affinity, humanised, IgG1 kappa antibody targeting interleukin 23 p19 that represe

112 udies demonstrate that effects of 10 mg Opra Kappa are largely consistent with those predicted for a

113 rase eta [Pol eta] and polymerase kappa [Pol kappa]) are recruited to the viral DNA replication cente

114 downregulation of the kappa opioid receptor (Kappa), as well as decreased DNA methylation in the seco

115 sion of receptor activator of nuclear factor-kappa B (NF-kappaB) ligand (RANKL), a potent osteoclast-

116 n signaling mechanisms is the nuclear factor-kappa B (NF-kappaB) pathway, which integrates multiple e

117 ains from key proteins in the nuclear factor kappa B (NF-kappaB) signaling pathway.

118 (TLR4)-dependent pathway via nuclear factor-kappa B (NF-kappaB), while simultaneously inhibiting exp

119 C activity, and inhibition of nuclear factor kappa B (NF-kB) translocation, were attributable to LC i

120 terleukin (IL)-8 promoter and nuclear factor kappa B (NFkappaB) activity, were observed within short

121 hances the rate of release of nuclear factor kappa B (NFkappaB) from DNA target sites in a process we

122 the HS-induced activation of nuclear factor kappa B and reduced the expression of proinflammatory pr

123 eby inhibited by inhibitor of nuclear factor kappa B kinase subunit beta (IKKbeta) to fine-tune the i

124 ts, and receptor activator of nuclear factor-kappa B ligand (RANKL) activity.

125 ctor-2, receptor activator of nuclear factor-kappa B ligand (RANKL), sclerostin, and Dickkopf Wnt sig

126 ceptor (TLR)2, TLR4, and nuclear factor (NF)-kappa B mRNA levels were analyzed using real-time quanti

127 drove hyperactivation of the nuclear factor kappa B p65 pathway.

128 on Ser536 phosphorylation of nuclear factor kappa B p65; this pathway may hold valuable targets for

129 -activated protein kinase and nuclear factor kappa B pathways in MDSCs was MyD88 dependent.

130 nscription factors, including nuclear factor kappa B, although its role in PCa was largely unknown.

131 HIV-1 gene transcription in a nuclear factor kappa B-dependent manner.

132 ointing to the suppression of nuclear factor kappa B-dependent transcription.

133 vo lipogenesis, and increased nuclear factor kappa B-mediated inflammation act in concert to mediate

134 evaluated by quantifying nuclear factor (NF)-kappa B-p65 and cytokine expression levels by quantitati

135 gen synthase kinase-3beta and nuclear factor kappa B.

136 on with receptor activator of nuclear factor kappa-B ligand (RANKL) resulted in a robust formation of

137 produce receptor activator of nuclear factor kappa-B ligand (RANKL), which, in turn, promotes the per

138 induces receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK-osteoprotegerin (OPG) signal

139 ession of LINC00305 activated nuclear factor-kappa beta (NF-kappaB) and that inhibition of NF-kappaB

140 macrophage-TLR4 and triggers nuclear factor kappa beta activation that upregulates secretion of proi

141 Concordance (Cohen unweighted kappa) between the PSF and the PSFEARL DS was 0.82 (95%

142 as a substrate for DNA polymerase kappa (pol kappa), but was a poor substrate for pols beta, delta, e

143 pecific GFAP isoforms (alpha, varepsilon, or kappa) by cell-based assays; and (3) clinical data avail

144 ficity, matching the hybrid character of the kappa-carrageenan polymer.

145 family 16 and cleave the beta-1,4 linkage of kappa-carrageenan.

146 s give new insight into the diversity of the kappa-carrageenase subfamily.

147 ghts into these features, we have focused on kappa-carrageenases from two distant bacterial phyla, wh

148 asein dissociation and the concentrations of kappa-casein and denatured whey protein in the serum, an

149 was more proteolytic than chymosin and that kappa-casein was proteolyzed.

150 S1-casein, 5 from alphaS2-casein, and 4 from kappa-casein.

151 ast one epitope in alphas1 -casein to 73% in kappa-casein.

152 ultaneous expression of both IgH-mu- and IgL-kappa-chains, without progressing through the stage of I

153 e report the characterization of chicken IFN-kappa (chIFN-kappa) near the type I IFN locus on the sex

154 gative percent agreement (NPA) (95% CI), and kappa coefficient (95% CI) for the BD Max xEBP assay for

155 eristic curve was between 0.94 and 0.96, and kappa coefficient (SD) between 0.764 (0.010) and 0.829 (

156 y meaningful bands with the highest weighted kappa coefficient of agreement (kappa = 0.69) was as fol

157 between SPT and sIgE was assessed by Cohen's kappa coefficient with different cutoff values.

158 agreement between DBS and plasma was 96.7% (kappa coefficient, 0.93; P < 0.0001).

159 und and magnetic resonance imaging was good (kappa coefficient=0.79).

160 ic and MR images and among readers, weighted kappa coefficients with quadratic weights were calculate

161 pus keratinocytes, and neutralization of IFN-kappa decreased IL-6 production by lupus keratinocytes.

162 To determine whether chIFN-kappa defines the antiviral state in developing chicken

163 Moreover, we find kappa exhibits noticeable anisotropy, with kappa zz bein

164 Surface Ig (sIg)kappa-expressing cells, isolated with mAb LK14 that reco

165 re glucocorticoid receptor binding regulates Kappa expression, unraveling a new mechanism mediating t

166 Cohen's kappa (kappa) for the SBS2 EEG and standard EEG for the epilept

167 and the surplus allocated to growth, and 1 - kappa fraction of assimilated energy is allocated to acc

168 that assimilated energy is partitioned, with kappa fraction of energy allocated to pay maintenance co

169 DNA methylation in the second intron of the Kappa gene.

170 nd for time-signal intensity curve analysis (kappa > 0.9) and the following parameters: AUGC90, K(tra

171 rfect diagnostic concordance (Cohen's kappa, kappa > 0.90) and an accuracy of 92% to 96%.

172 intrareader reproducibility were very good (kappa > 0.90).

173 zed in the preferential order beta->alphas1->kappa->alphas2.

174 ty to salvinorin A (EC50 = 0.6 +/- 0.2 nM at kappa; >10000 nM at mu and delta).

175 lasts and tracheal organ cultures with chIFN-kappa imparted cellular protections against viral infect

176 level were not significantly associated with kappa in 18 of 19 modeled conditions.

177 Modest adverse events related to Opra Kappa included pruritus, observed in a subset of individ

178 t with type I interferons (IFN-alpha and IFN-kappa) increased IL-6 production by control keratinocyte

179 wever, the type I interferon regulator IRF1, kappa interferon (IFN-kappa), and viral restriction fact

180 showed that child abuse is associated in the Kappa intron with a selective reduction in levels of DNA

181 ry and syntenic analyses indicate that chIFN-kappa is a type I IFN with conserved genetic features an

182 on signal binding protein for immunoglobulin kappa J region (RBPjkappa), key modulators of adipogenes

183 Cohen's kappa (kappa) for the SBS2 EEG and standard EEG for the

184 The weighted Kappa (kappa) statistic for agreement between automated

185 y ventilated patients assessed using Cohen's kappa (kappa) were 0.82 and 1, respectively, p<0.001.

186 ng a modified Bland-Altman model and Cohen's kappa (kappa).

187 near-perfect diagnostic concordance (Cohen's kappa, kappa > 0.90) and an accuracy of 92% to 96%.

188 (11) , and anisotropic thermal conductivity (kappa|| /kappa perpendicular ) of 18.

189 parameterize these results in terms of both kappa-Kohler theory and adsorption activation theory for

190 d using percent exact agreement and weighted kappa (Kw ) for stage, zone, plus, referral-warranted RO

191 eby reduces the lattice thermal conductivity kappa l .

192 multilayer (RML) structure to further reduce kappa l .

193 echanism, while it substantially reduces the kappa l of many-period SLs by breaking the phonon cohere

194 erfacial species mixing always increases the kappa l of RMLs owing to the dominance of incoherent pho

195 ping a binary RML with impurities can reduce kappa l significantly, especially when the impurity atom

196 Nurse sharks express four L chain isotypes, kappa, lambda, sigma, and sigma-2, encoded by 35 functio

197 onal (e.g. 12) or highly selective (e.g. 16) kappa ligands.

198 t to investigate canonical nuclear factor of kappa light chain (NF-kappaB) signaling in B cells from

199 naling lymphocyte-activating molecule 7, and kappa light chain are under investigation as CAR targets

200 ical brake on proinflammatory nuclear factor kappa light chain enhancer of activated B cells signalin

201 immunoglobulin G gammopathy, 20 (58.8%) had kappa light chains.

202 d inhibitory IkappaBalpha (nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibito

203 down monocytes have sustained nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kapp

204 and metastasis-through a TLR4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kapp

205 nger RNA expression levels of nuclear factor kappa-light-chain-enhancer of activated B cells and A20

206 activated protein kinase and nuclear factor kappa-light-chain-enhancer of activated B cells and nega

207 the capacity to phosphorylate nuclear factor kappa-light-chain-enhancer of activated B cells in lymph

208 activated protein kinase and nuclear factor kappa-light-chain-enhancer of activated B cells were det

209 ss capable in phosphorylating nuclear factor kappa-light-chain-enhancer of activated B cells.

210 (11%) persons, agreement was poor (weighted kappa <0.18, 95% confidence interval, 0.13, 0.23).

211 ts with late systolic or multiple jets (both kappa<0.2).

212 y developed selective KOP-r-antagonist, Opra Kappa (LY2456302; CERC-501), has medication-like duratio

213 d tissue (MALT) lymphoma with immunoglobulin kappa monotype.

214 characterization of chicken IFN-kappa (chIFN-kappa) near the type I IFN locus on the sex-determining

215 show that the weak temperature dependence of kappa observed in experiments should not be caused by ph

216 adjudicated bleeding events was poor, with a kappa of 0.24 (95% CI, 0.19 to 0.30) for any hospitalize

217 of 113; 95% CI: 0.59, 0.76), with a weighted kappa of 0.59 (95% CI: 0.47, 0.71).

218 7 of 113; 95% CI: 0.89, 0.98), with weighted kappa of 0.90 (95% CI: 0.81, 0.99).

219 We investigate lattice thermal conductivity kappa of MgSiO3 perovskite (pv) by ab initio lattice dyn

220 .3: a room-temperature thermal conductivity (kappa) of 0.4(1) W/mK was measured on a pellet with pref

221 analgesics and mediates the long duration of kappa opioid antidepressants by an uncharacterized, arre

222 anterior insula with a downregulation of the kappa opioid receptor (Kappa), as well as decreased DNA

223 0,488H promoted phosphorylation of the mouse kappa opioid receptor (KOPR) at residues S356, T357, T36

224 nd for aversion induced by thermal pain or a kappa opioid receptor agonist.

225 ks acute analgesic tolerance to morphine and kappa opioid receptor inactivation in vivo.

226 micro and delta opioid receptor antagonist, kappa opioid receptor partial agonist that has recently

227 Stressful experiences potently activate kappa opioid receptors (kappaORs).

228 on a series of small molecules targeting the kappa-opioid (KOP) receptor featuring a diphenethylamine

229 is an effective PAM at the mu-OR and at the kappa-opioid receptor (kappa-OR), but it is ineffective

230 The kappa-opioid receptor (KOP-r) system and its endogenous

231 Administration of the kappa-opioid receptor (KOR) antagonist JDTic (30 mg/kg,

232 Administration of a kappa-opioid receptor (KOR) antagonist reduced stress ef

233 The kappa-opioid receptor (KOR) has been implicated in depre

234 The kappa-opioid receptor (KOR) has emerged as a promising t

235 Endogenous dynorphin signaling via the kappa-opioid receptor (KOR) in the nucleus accumbens (NA

236 show single-digit nanomolar to subnanomolar kappa-opioid receptor affinity, full kappa agonistic act

237 tionality on the A-ring in its activity as a kappa-opioid receptor agonist.

238 tra-pPVT administration of OrxA+/-DynA+/-the kappa-opioid receptor antagonist nor-binaltorphimine (No

239 ablished the colocalization of mu-opioid and kappa-opioid receptor genes and OT genes at the OT-relea

240 peptide dynorphin, which acts at presynaptic kappa-opioid receptors (KORs) on dopaminergic afferents

241 First, Dbx1 preBotC neurons express kappa-opioid receptors in addition to mu-opioid receptor

242 rphin which can inhibit dopamine release via kappa-opioid receptors.

243 This indicates that the kappa-opioid system in the pPVT counteracts OrxA-induced

244 ter agreement between raters and modalities (kappa or ICC > 0.6).

245 the mu-OR and at the kappa-opioid receptor (kappa-OR), but it is ineffective at the nociceptin recep

246 ioid receptor types (micro-OR, delta-OR, and kappa-OR).

247 The affinity of BMS-986187 for delta-ORs and kappa-ORs is approximately 20- to 30-fold higher than fo

248 An immunoglobulin M (IgM) kappa paraprotein was detected in 86%; the remainder had

249 d anisotropic thermal conductivity (kappa|| /kappa perpendicular ) of 18.

250 ral DNA replication and that Pol eta and Pol kappa play an important role in HBoV1 DNA replication.

251 al to dGTP as a substrate for DNA polymerase kappa (pol kappa), but was a poor substrate for pols bet

252 DNA polymerase kappa (Pol kappa), which has been implicated in both nuc

253 ses (polymerase eta [Pol eta] and polymerase kappa [Pol kappa]) are recruited to the viral DNA replic

254 -10%) in the isogenic cells deficient in Pol kappa, Pol iota or Pol zeta, suggesting the mutual invol

255 % [40 of 162]), with poor to fair agreement (kappa range, -0.02 to 0.42).

256 diagnosis and sector count was substantial (kappa range, 0.66 [95% CI, 0.47-0.85] to 0.75 [95% CI, 0

257 kappa ranged from 0.002 +/- 0.001 to 0.818 +/- 0.094, wh

258 chIFN-kappa regulated the IFN-stimulated response element sign

259 olyps with perfect intra-observer agreement (kappa score of 1).

260 haracteristics and area under the curve, and kappa score.

261 Cohen's kappa statistic was calculated to establish agreement be

262 The unweighted kappa statistic was used to analyze the intragrader agre

263 ds for each condition was assessed using the kappa statistic.

264 and frailty was assessed using the weighted kappa statistic.

265 ssessed by using the linearly weighted Cohen kappa statistic.

266 months after discharge was assessed with the kappa statistic.

267 The weighted Kappa (kappa) statistic for agreement between automated noninva

268 interobserver agreement was estimated using kappa statistics and Gwet second-order agreement coeffic

269 reement of symptom report was analyzed using kappa statistics and McNemar tests.

270 Interreader agreement was assessed with kappa statistics and the intraclass correlation coeffici

271 Subgroup analyses examined differences in kappa statistics based on age, race, marital status, edu

272 Simple kappa/weighted kappa statistics for severity of H/Ma: all fields 0.61/0

273 nician AE reports was analyzed with weighted kappa statistics.

274 nterprotocol agreement was assessed by using kappa statistics.

275 ivation is suggested as: sigma-2 followed by kappa, then sigma and lambda.

276 t property of high dielectric constant (high-kappa) thin films with far reaching implications.

277 320 K demonstrate a shift of the peak in the kappa to lower temperature.

278 arbonates that were strongly correlated with kappa underscoring the role that mineralogy, including s

279 g sensibility of the ICD-11 usability (Cohen-kappa value 0.75).

280 The overall kappa value for diagnosis was 0.43 (95% confidence inter

281 Kappa value for interobserver agreement in detecting CC

282 A kappa value of 0.479 was found for late enhancement (P <

283 ategorized based on degree of dysplasia, the kappa value was 0.22 (95% CI, 0.11-0.29) for non-dysplas

284 The multirater kappa value was 0.73.

285 The kappa values for all diagnoses made by European patholog

286 The kappa values for interobserver agreement were 0.84 for f

287 tly more CCN active and hygroscopic; average kappa values range from 0.242 to 0.439 and are as high a

288 greement, negative agreement, and interrater kappa values ranging from 17.9% to 42.9%, 91.7% to 98.6%

289 kappa Values were calculated for inter-observer agreemen

290 kappa Values, intraclass correlation coefficients (ICCs)

291 rver agreement was calculated by using Cohen kappa values.

292 evels, respectively, with associated Fleiss' kappa-values of 0.54, 0.50, and 0.57.

293 Secretion of keratinocyte-specific IFN-kappa was significantly increased after toll-like recept

294 Cohen's kappa was used to assess reliability of interobserver ag

295 Simple kappa/weighted kappa statistics for severity of H/Ma: al

296 demonstrated that only cells containing pol kappa were able to incorporate N(2) -4-ethynylbenzyl-dG

297 lated patients assessed using Cohen's kappa (kappa) were 0.82 and 1, respectively, p<0.001.

298 DNA polymerase kappa (Pol kappa), which has been implicated in both nucleotide exc

299 ctional data on the interaction of the chIFN-kappa with RNA viruses of poultry and public health impo

300 d kappa exhibits noticeable anisotropy, with kappa zz being the largest component and [Formula: see t